Shares of Regeneron Pharmaceuticals Inc. gained 1.4% premarket on Monday after the company said late Friday that the U.S. Food and Drug Administration had...
Shares of Regeneron Pharmaceuticals Inc.
gained 1.4% premarket on Monday after the company said late Friday that the U.S. Food and Drug Administration had approved a higher-dose formulation of its macular degeneration treatment Eylea. The eight-milligram Eylea injection, jointly developed by Regeneron and Bayer AG BAYRY, -1.36%, is approved for treatment of wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy, Regeneron said in a release.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Maiden Pharmaceuticals: Fury in The Gambia a year after cough syrup deathsGrieving parents say regulators in both India and The Gambia failed their young children.
Weiterlesen »
On Abortion Pills, Federal Appeals Court Prescribes Justice for FDAAmericans concerned about the safety, health, and welfare of women and girls in this country received welcome news last week.
Weiterlesen »
Harvard gut doctor shares 4 foods that cause inflammation—and what she eats insteadWhat you eat has a large impact on inflammation in the body. Harvard gut doctor Jacqueline Wolf shares the high-inflammatory foods she stays away from—and what she includes in her diet instead.
Weiterlesen »
‘American Idol’ Judge Luke Bryan Shares ‘Heartbreaking’ Update With FansFeel better, Luke!
Weiterlesen »
Schitt’s Creek EP Shares Lesson Learned from the ShowSchitt’s Creek is all about the characters.
Weiterlesen »